Thilo Heckrodt

Thilo Heckrodt is an accomplished medicinal chemist currently serving as Vice President of Medicinal Chemistry at Kimia Therapeutics since December 2023. Prior to this role, Thilo made significant contributions at PTC Therapeutics, Inc., where positions included Executive Director and Senior Director of Chemistry from April 2021 to November 2023. Thilo also held the position of Director of Medicinal Chemistry at Assembly Biosciences, Inc. from September 2019 to April 2021. With a lengthy tenure at Rigel Pharmaceuticals Inc. between January 2010 and September 2019, Thilo progressed through roles such as Staff Scientist, Group Leader, and Senior Scientist in Medicinal Chemistry. Thilo's academic background includes a Postdoctoral fellowship in Organic Chemistry from the University of California, Berkeley, and a Ph.D. in Organic Chemistry from the University of Vienna.